Annual Total Liabilities
$4.58 M
-$7.46 M-61.93%
December 31, 2023
Summary
- As of February 8, 2025, AKTX annual total liabilities is $4.58 million, with the most recent change of -$7.46 million (-61.93%) on December 31, 2023.
- During the last 3 years, AKTX annual total liabilities has fallen by -$636.50 thousand (-12.19%).
- AKTX annual total liabilities is now -78.35% below its all-time high of $21.17 million, reached on December 31, 2015.
Performance
AKTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$9.43 M
+$649.00 K+7.39%
September 1, 2024
Summary
- As of February 8, 2025, AKTX quarterly total liabilities is $9.43 million, with the most recent change of +$649.00 thousand (+7.39%) on September 1, 2024.
- Over the past year, AKTX quarterly total liabilities has increased by +$649.00 thousand (+7.39%).
- AKTX quarterly total liabilities is now -75.09% below its all-time high of $37.84 million, reached on September 30, 2015.
Performance
AKTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
AKTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -61.9% | +7.4% |
| 3 y3 years | -12.2% | +180.9% |
| 5 y5 years | -6.8% | +27.1% |
AKTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.9% | at low | at high | +209.6% |
| 5 y | 5-year | -61.9% | at low | -15.2% | +209.6% |
| alltime | all time | -78.3% | +291.3% | -75.1% | +704.9% |
Akari Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.43 M(+7.4%) |
| Jun 2024 | - | $8.78 M(+38.8%) |
| Mar 2024 | - | $6.33 M(+38.0%) |
| Dec 2023 | $4.58 M(-61.9%) | $4.58 M(-12.4%) |
| Jun 2023 | - | $5.23 M(+71.8%) |
| Dec 2022 | $12.04 M(+97.6%) | - |
| Jun 2022 | - | $3.05 M(-44.9%) |
| Mar 2022 | - | $5.52 M(-9.4%) |
| Dec 2021 | $6.09 M(+16.7%) | $6.09 M(+81.6%) |
| Sep 2021 | - | $3.36 M(+3.5%) |
| Jun 2021 | - | $3.24 M(-16.9%) |
| Mar 2021 | - | $3.90 M(-25.2%) |
| Dec 2020 | $5.22 M(-19.3%) | $5.22 M(-40.9%) |
| Sep 2020 | - | $8.84 M(-20.5%) |
| Jun 2020 | - | $11.11 M(+36.3%) |
| Mar 2020 | - | $8.15 M(+26.0%) |
| Dec 2019 | $6.47 M(+31.6%) | $6.47 M(-12.8%) |
| Sep 2019 | - | $7.42 M(+13.7%) |
| Jun 2019 | - | $6.52 M(-14.0%) |
| Mar 2019 | - | $7.59 M(+54.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $4.92 M(-58.7%) | $4.92 M(-22.2%) |
| Sep 2018 | - | $6.32 M(-25.5%) |
| Jun 2018 | - | $8.49 M(-7.4%) |
| Mar 2018 | - | $9.17 M(-22.9%) |
| Dec 2017 | $11.90 M(+1.1%) | $11.90 M(+26.8%) |
| Sep 2017 | - | $9.39 M(+2.0%) |
| Jun 2017 | - | $9.20 M(-34.8%) |
| Mar 2017 | - | $14.12 M(+20.0%) |
| Dec 2016 | $11.77 M(-44.4%) | $11.77 M(+6.7%) |
| Sep 2016 | - | $11.03 M(-35.3%) |
| Jun 2016 | - | $17.05 M(+2.7%) |
| Mar 2016 | - | $16.60 M(-21.6%) |
| Dec 2015 | $21.17 M(+1707.6%) | $21.17 M(-44.0%) |
| Sep 2015 | - | $37.84 M(+1804.5%) |
| Jun 2015 | - | $1.99 M(+15.4%) |
| Mar 2015 | - | $1.72 M(+47.0%) |
| Dec 2014 | $1.17 M(-42.0%) | $1.17 M |
| Dec 2013 | $2.02 M(-55.0%) | - |
| Dec 2012 | $4.48 M(+78.3%) | - |
| Dec 2011 | $2.51 M | - |
FAQ
- What is Akari Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Akari Therapeutics?
- What is Akari Therapeutics annual total liabilities year-on-year change?
- What is Akari Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Akari Therapeutics?
- What is Akari Therapeutics quarterly total liabilities year-on-year change?
What is Akari Therapeutics annual total liabilities?
The current annual total liabilities of AKTX is $4.58 M
What is the all time high annual total liabilities for Akari Therapeutics?
Akari Therapeutics all-time high annual total liabilities is $21.17 M
What is Akari Therapeutics annual total liabilities year-on-year change?
Over the past year, AKTX annual total liabilities has changed by -$7.46 M (-61.93%)
What is Akari Therapeutics quarterly total liabilities?
The current quarterly total liabilities of AKTX is $9.43 M
What is the all time high quarterly total liabilities for Akari Therapeutics?
Akari Therapeutics all-time high quarterly total liabilities is $37.84 M
What is Akari Therapeutics quarterly total liabilities year-on-year change?
Over the past year, AKTX quarterly total liabilities has changed by +$649.00 K (+7.39%)